These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6140786)

  • 21. [Treatment of peptic ulcer with histamine H2-receptor antagonists].
    Radbil' OS
    Sov Med; 1977 Nov; (11):111-9. PubMed ID: 24276
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma sex steroid transport and histamine H2-receptor antagonists. Clinical implications.
    Berta L; Dusio P; Fortunati N; Fazzari A; Crua MR; Frairia R; Gaidano G
    Ann N Y Acad Sci; 1988; 538():304-12. PubMed ID: 2903712
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of cholinesterases by histamine 2 receptor antagonist drugs.
    Laine-Cessac P; Turcant A; Premel-Cabic A; Boyer J; Allain P
    Res Commun Chem Pathol Pharmacol; 1993 Feb; 79(2):185-93. PubMed ID: 8095733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology update. Anti-peptic ulcer agents--Part I. A histamine 2 receptor antagonist.
    Romankiewicz JA
    J Pract Nurs; 1981 Jan; 31(1):15-6. PubMed ID: 6108367
    [No Abstract]   [Full Text] [Related]  

  • 25. Can the H2 receptor antagonists change the natural history of duodenal ulcer disease?
    Bardhan KD
    Am J Gastroenterol; 1994 Jan; 89(1):3-6. PubMed ID: 7903845
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histamine H2-receptor antagonists in the treatment of peptic ulcer disease.
    Wood JR; McIsaac RL
    S Afr Med J; 1988 Jul; 74 Suppl():51-4. PubMed ID: 3291155
    [No Abstract]   [Full Text] [Related]  

  • 28. Innovations in peptic ulcer disease: histamine 2-receptor antagonists.
    Romankiewicz N
    J Pract Nurs; 1983; 33(8):8-9. PubMed ID: 6140313
    [No Abstract]   [Full Text] [Related]  

  • 29. The success of histamine-2 receptor antagonists.
    Morris AI
    Scand J Gastroenterol Suppl; 1992; 194():71-5. PubMed ID: 1363678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of the nonprescription drug consumer's understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburn.
    Ciociola AA; Sirgo MA; Pappa KA; McGuire JA; Fung K
    Am J Ther; 2001; 8(6):387-98. PubMed ID: 11704777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
    Sevvel S; Ananthakrishnan N; Kate V
    Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
    Mainguet P
    Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antacids, histamine H2 receptor antagonists].
    Raphaël M
    Soins; 1988 Apr; (511):I-II. PubMed ID: 2899911
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of ranitidine on prognosis after simple closure of perforated duodenal ulcer.
    Singh K; Chhina RS; Ghosh A; Kaura R
    Trop Gastroenterol; 1999; 20(2):90-2. PubMed ID: 10484900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM; Misiewicz G
    Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
    [No Abstract]   [Full Text] [Related]  

  • 37. [The treatment with ranitidine of 40 gastroduodenal ulceration: evaluation of an open study (author's transl)].
    Barbier P; Dumont A; Adler M
    Acta Gastroenterol Belg; 1979; 42(7-8):268-74. PubMed ID: 44956
    [No Abstract]   [Full Text] [Related]  

  • 38. Misuse of antacid and H2 receptor antagonists in routine clinical practice.
    Wander GS; Gulati R; Bhatia RS
    J Assoc Physicians India; 1992 Mar; 40(3):207. PubMed ID: 1353075
    [No Abstract]   [Full Text] [Related]  

  • 39. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
    Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T
    Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H2 receptor antagonist usage in Missouri Medicaid recipients.
    Douglas KC; Dykstra AM; Fitzpatrick W; Lowrey L; Prosser TR; Rush DR; Stelmach WJ
    Mo Med; 1988 Dec; 85(12):779-80. PubMed ID: 2907095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.